FIELD: medicine; pharmacology.
SUBSTANCE: pharmaceutical composition contains aripiprazole and in the form of a complex of inclusion with β-cyclodextrin, preferably, sulphonic-propyl carbinol aether of β-cyclodextrin (SBECD). The method of treatment of schizophrenia includes introduction of the specified composition to the patient requiring treatment.
EFFECT: irritation decrease in the place of an intramuscular injection.
18 cl, 6 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL DEPOT-PREPARATIONS FOR INJECTION | 2003 |
|
RU2310450C2 |
| COMPOSITIONS CONTAINING ACETAMINOPHENE AND CYCLODEXTRIN SULFAOKYL ETHER | 2017 |
|
RU2772384C2 |
| COMPOSITIONS CONTAINING POLYSACCHARIDE MATRIX FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS | 2017 |
|
RU2748261C2 |
| BENDAMUSTINE AND CYCLOPOLYSACCHARIDE COMPOSITIONS | 2010 |
|
RU2734236C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING WATER-INSOLUBLE ANTIPSYCHOTIC AGENT AND SORBITAN ESTERS | 2012 |
|
RU2627469C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-INSOLUBLE ANTIPSYCHOTIC DRUG AND SORBITAN ESTERS | 2012 |
|
RU2757859C2 |
| PARENTERAL LIQUID PREPARATION INCLUDING CARBAMATE COMPOUND | 2017 |
|
RU2761041C2 |
| COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN | 2018 |
|
RU2787621C2 |
| COMPOSITIONS OF BENDAMUSTINE AND CYCLOPOLYSACCHARIDE | 2010 |
|
RU2591804C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
